Additional Information:
http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-13-008.html
Description:
The NIH Transformative Research Awards complements NIH’s
traditional, investigator-initiated grant programs by supporting individual
scientists or groups of scientists proposing groundbreaking, exceptionally
innovative, original and/or unconventional research with the potential to create
new scientific paradigms, establish entirely new and improved clinical
approaches, or develop transformative technologies. Little or no preliminary
data are expected. Projects must clearly demonstrate the potential to produce a
major impact in a broad area of biomedical or behavioral research.
Friday, August 2, 2013
Friday, July 26, 2013
Research Projects Related to Diabetes Care in Older Adults
Additional Information:
http://foundationcenter.org/pnd/rfp/rfp_item.jhtml?id=429000049
Description:
The American Diabetes Association, with support from Eli Lilly and Company, is inviting applications for original and innovative translational and clinical research proposals focused on improving the evidence base and understanding of the goals, barriers, and effects of treatments and interventions (beneficial and adverse) in older adults with both type 1 and type 2 diabetes.
The aim of the initiative is to further identify the safest and most effective means of diabetes treatment for this population.
Translational and clinical research projects will receive a maximum of $550,000 over three years (no more than $200,000 per year in any one year, including indirect costs).
To be eligible, applicants must hold a Ph.D., M.D., Pharm.D., D.P.M., or equivalent health- or science-related degree. In addition, applicants must hold full-time faculty positions or the equivalent at university-affiliated institutions or other nonprofit research and clinical institutions within the United States or one of its territories.
See the ADA Web site for complete program information and application guidelines.
http://foundationcenter.org/pnd/rfp/rfp_item.jhtml?id=429000049
Description:
The American Diabetes Association, with support from Eli Lilly and Company, is inviting applications for original and innovative translational and clinical research proposals focused on improving the evidence base and understanding of the goals, barriers, and effects of treatments and interventions (beneficial and adverse) in older adults with both type 1 and type 2 diabetes.
The aim of the initiative is to further identify the safest and most effective means of diabetes treatment for this population.
Translational and clinical research projects will receive a maximum of $550,000 over three years (no more than $200,000 per year in any one year, including indirect costs).
To be eligible, applicants must hold a Ph.D., M.D., Pharm.D., D.P.M., or equivalent health- or science-related degree. In addition, applicants must hold full-time faculty positions or the equivalent at university-affiliated institutions or other nonprofit research and clinical institutions within the United States or one of its territories.
See the ADA Web site for complete program information and application guidelines.
NIMHD Social, Behavioral, Health Services, and Policy Research on Minority Health and Health Disparities (R01)
Additional Information:
http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-13-006.html
Description:
http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-13-006.html
Description:
The purpose of this Funding Opportunity Announcement (FOA)
is to solicit innovative social, behavioral, health services, and policy
research that can directly and demonstrably contribute to the elimination of
health disparities. Projects may involve primary data collection or secondary
analysis of existing datasets. Projects that examine understudied health
conditions; examine the effectiveness of interventions, services, or policies
for multiple health disparity populations; and/or directly measure the impact of
project activities on levels of health disparities are particularly encouraged.
FOA #: RFA-MD-13-006
Monday, July 22, 2013
Notice of Participation of the NIH Common Fund in PA-12-149 "Research Supplements to Promote Diversity in Health-Related Research (Admin Supp)"
Description:
The purpose of this Notice is to inform potential applicants that the Office of Strategic Coordination (Common Fund) has been added to the participating components for PA-12-149 entitled "Research Supplements to Promote Diversity in Health-Related Research (Admin Supp)".
Additional Information:
http://grants.nih.gov/grants/guide/notice-files/NOT-RM-13-012.html
The purpose of this Notice is to inform potential applicants that the Office of Strategic Coordination (Common Fund) has been added to the participating components for PA-12-149 entitled "Research Supplements to Promote Diversity in Health-Related Research (Admin Supp)".
Additional Information:
http://grants.nih.gov/grants/guide/notice-files/NOT-RM-13-012.html
Friday, June 28, 2013
ADA and Lilly Clinical Research Award: Diabetes Care in Older Adults
Additional Information:
Description:
Applications for clinical and translational research studies focused on improving the evidence base and understanding of the goals, barriers, and effects of treatments and interventions (beneficial and adverse) in the older adult population with type 1 and type 2 diabetes will be accepted. Prospective, patient-orients studies are preferred.
Each investigator must submit an independent research grant application using the American Diabetes Association online research application forms. The application deadline for the American Diabetes Association and Lilly Clinical Research Award: Diabetes Care in Older Adults is September 16, 2013, for funding beginning January 1, 2014.
Friday, June 14, 2013
Addressing Methodological Challenges in Research for Patients with Multiple Chronic Conditions (R21)
Additional Information:
http://grants.nih.gov/grants/guide/rfa-files/RFA-HS-14-002.html
Description:
http://grants.nih.gov/grants/guide/rfa-files/RFA-HS-14-002.html
Description:
This funding Opportunity Announcement (FOA) solicits
Exploratory Research (R21) grant applications from organizations that propose to
test and validate new methods involving research on patients with multiple
chronic conditions (MCC).
With this FOA, AHRQ is investing in the adaptation,
refinement or development of research methods that will enhance our
understanding of how to provide high-quality health care for patients with
MCC. Applicants must:
1. Propose an adaptation or refinement to existing
methodology or propose the development of a new methodology for studying people
with MCC
2. Validate and assess the proposed methodology
LOI Due: 7/19/13
Application: 8/28/13
Rapid Secondary Analysis to Optimize Care for Patients with Multiple Chronic Conditions (R01)
Additional Information:
http://grants.nih.gov/grants/guide/rfa-files/RFA-HS-14-001.html
Description:
http://grants.nih.gov/grants/guide/rfa-files/RFA-HS-14-001.html
Description:
This funding opportunity announcement (FOA) solicits Large
Research (R01) grant applications from organizations with large data sets to
conduct research to optimize processes and treatments that provide rapid and
relevant information to the clinical community to best care for patients with
multiple chronic conditions (MCC).
LOI Due: 7/19/13
Application Date: 8/28/13
Subscribe to:
Posts (Atom)